This multicenter, prospective study (ClinicalTrials.gov identifier: NCT04703153) enrolled patients across the United States and Singapore. Patients were tested with tissue NGS, LHM, and G360 ctDNA.
Primary Analysis of EPIK-O/ENGOT-ov61: Alpelisib Plus Olaparib Versus Chemotherapy in Platinum-Resistant or Platinum-Refractory High-Grade Serous Ovarian Cancer Without BRCA Mutation Eligible patients ...
Vitestro, the pioneer in medical robotics advancing automated diagnostic blood collection, today announced the publication of its multicenter clinical trial manuscript, "Performance, Safety, and ...
A newly published multicenter clinical study cites measurable improvements in cellulite and skin laxity using non-invasive ...
Introduction: Type 2 diabetes mellitus (T2DM), a chronic metabolic disease, affects millions of people worldwide, causes numerous complications, (eg, cardiovascular dise ...
On March 12, 2026, the first implant of the ProStyle M(R) Transcatheter Mitral Valve System (ProStyle M(R) ) was successfully completed under pure ultrasound guidance as part of its confirmatory ...
KingstronBio takes innovation as its core driving force and has long been deeply engaged in the heart valve field. The ...